Skip to main content

Healthy

2160
Pipeline Programs
30
Companies
50
Clinical Trials
11 recruiting
16
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
2023
11
28
5
20
73
Early DiscoveryClinical DevelopmentMarket

Drug Modality Breakdown

Small Molecule
28875%
Peptide
4111%
Monoclonal Antibody
4010%
Vaccine
164%
RNA Therapeutic
10%
+ 3653 programs with unclassified modality

On Market (16)

Approved therapies currently available

Johnson & Johnson
XARELTOApproved
Johnson & Johnson
oral2011
6.3B Part D
Johnson & Johnson
INVOKANAApproved
canagliflozin
Johnson & Johnson
oral2013
357M Part D
AbbVie
BOTOXApproved
onabotulinumtoxina
AbbVie
Acetylcholine Release Inhibitor [EPC]single-use1991
112M Part D
Otsuka
JYNARQUEApproved
tolvaptan
Otsuka
Vasopressin V2 Receptor Antagonist [EPC]oral2018
76M Part D
Johnson & Johnson
INVOKAMETApproved
canagliflozin and metformin hydrochloride
Johnson & Johnson
oral2014
22M Part D
Pfizer
NEURONTINApproved
gabapentin
Pfizer
oral2002
20M Part D
Otsuka
SAMSCAApproved
tolvaptan
Otsuka
Vasopressin V2 Receptor Antagonist [EPC]oral2009
12M Part D
GSK
SELZENTRYApproved
maraviroc
GSK
CCR5 Co-receptor Antagonist [EPC]oral2016
9M Part D
Otsuka
TOLVAPTANApproved
tolvaptan
Otsuka
oral2025
3M Part D
Pfizer
VFENDApproved
voriconazole
Pfizer
Azole Antifungal [EPC]intravenous2002
10K Part D
Eli Lilly and Company
INLURIYOApproved
imlunestrant
Eli Lilly and Company
Estrogen Receptor Antagonist [EPC]oral2025
Johnson & Johnson
DURAGESIC-50Approved
Johnson & Johnson
transdermal1990
Novartis
OMNIPREDApproved
prednisolone acetate
Novartis
ophthalmic1973
AbbVie
BOTOX COSMETICApproved
onabotulinumtoxina
AbbVie
Acetylcholine Release Inhibitor [EPC]single-use1991
Baxter
ANCEF IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINERApproved
cefazolin sodium
Baxter
injection
Baxter
MYXREDLINApproved
insulin human
Baxter
Insulin [EPC]intravenous2019

Competitive Landscape

427 companies ranked by most advanced pipeline stage

Pfizer
366 programs
339
1
2
7
10
Alivium®Phase 41 trial
Cymbalta CapsulesPhase 41 trial
Cymbalta capsulePhase 41 trial
MaravirocPhase 4
PregabalinPhase 41 trial
+361 more programs
Active Trials
NCT01509105Completed649Est. Jan 2016
NCT00508950Completed152Est. Jun 2016
NCT00913406Completed232Est. May 2006
+394 more trials
AstraZeneca
172 programs
165
2
EsomeprazolePhase 4Small Molecule1 trial
NexiumPhase 41 trial
14C-AZD1236Phase 11 trial
ACH-0145228Phase 11 trial
ACH-0145228: Immediate ReleasePhase 11 trial
+167 more programs
Active Trials
NCT01031758Completed18Est. Jun 2010
NCT00860821Completed20Est. Oct 2009
NCT01308372Completed9,246Est. Oct 2011
+164 more trials
Sharp Therapeutics
106 programs
99
1
3
1
ertapenemPhase 4
Comparator: Varicella Zoster Virus VaccinePhase 3Vaccine
V110, pneumococcal vaccine polyvalentPhase 3Vaccine
V181Phase 3
V540A-2Phase 2
+101 more programs
MSD
106 programs
99
1
3
1
ertapenemPhase 41 trial
Comparator: Varicella Zoster Virus VaccinePhase 3Vaccine1 trial
V110, pneumococcal vaccine polyvalentPhase 3Vaccine1 trial
V181Phase 31 trial
V540A-2Phase 21 trial
+101 more programs
Active Trials
NCT03942705Completed200Est. May 2021
NCT06675994Not Yet Recruiting80Est. Dec 2025
NCT00658554Completed24Est. Jun 2008
+103 more trials
Eli Lilly and Company
Eli Lilly and CompanyINDIANAPOLIS, IN
60 programs
1
CelecoxibN/ASmall Molecule
Harvard Apparatus syringe pumpN/A
PropranololN/ASmall Molecule
5 mg empagliflozin/850 mg metformin FDCPHASE_1
AbemaciclibPHASE_1Small Molecule
+55 more programs
Sandoz
60 programs
47
1
1
4
DarifenacinPhase 41 trial
Povidone K25 eye dropsPhase 41 trial
Prednisolone acetatePhase 41 trial
olanzapinePhase 41 trial
rMenBPhase 21 trial
+55 more programs
Active Trials
NCT02479854Completed24Est. Apr 2014
NCT02480049Completed26Est. Aug 2014
NCT00882570Completed40Est. May 2005
+56 more trials
Human BioSciences
8
2
5
1
2
MEDI3414 [Influenza A/H1N1 live attenuated, intranasal]Phase 41 trial
Testosterone EnanthatePhase 41 trial
Testosterone gelPhase 2/31 trial
AcylinePhase 21 trial
Dimethandrolone-UndecanoatePhase 2
+53 more programs
Active Trials
NCT01007188Completed18Est. May 2010
NCT01802151Completed83Est. Oct 2012
NCT02612597Unknown20Est. Apr 2016
+52 more trials
Lundbeck
38 programs
33
3
EscitalopramPhase 41 trial
Escitalopram 20 mgPhase 41 trial
escitalopram and tramadolPhase 41 trial
Cohort A1: Lu AE58054 or placeboPhase 11 trial
Drug CocktailPhase 11 trial
+33 more programs
Active Trials
NCT00150527Completed8Est. Dec 2007
NCT00612079Completed30Est. Nov 2008
NCT01975779Completed42
+34 more trials
Biocorp
33 programs
17
3
3
2
1
bOPVPhase 41 trial
DTP/HB/Hib VaccinePhase 3Vaccine1 trial
Ulmus macrocarpa water extractPhase 31 trial
HRIGPhase 2/31 trial
PentavalenPhase 2/31 trial
+28 more programs
Active Trials
NCT05749068Completed10Est. Oct 2022
NCT05939336Active Not Recruiting40Est. Jun 2026
NCT05206864Completed32Est. Feb 2022
+30 more trials
Johnson & Johnson
1
Brush OnlyN/A1 trial
Characterization of the Edge of Soft Contact Lens and Its Interaction With Ocular SurfaceN/A1 trial
Evaluation of Cow Milk-Based Formulas - Functional ProteinsN/A1 trial
Sunscreen C Color 2.0 SPF 70N/A1 trial
Sunscreen Color tone 2.0N/A1 trial
+21 more programs
Active Trials
NCT06798441Completed161Est. Feb 2025
NCT00707291Completed61Est. Jun 2011
NCT00916565Completed139
+32 more trials
ViiV Healthcare
26 programs
13
1
1
2
MaravirocPhase 4
Meningococcal BPhase 4
MaravirocPhase 2
MEDI 517Phase 1/2
CefadroxilPhase 1
+21 more programs
GSK
23 programs
1
Nasal LPS sprayN/A1 trial
Normal Control Cohort Sample BankN/A1 trial
Pilot Study to Assess Feasibility, Reliability and Validity of the e-SSRS-IVRN/A1 trial
RaltegravirN/ASmall Molecule1 trial
RaltegravirN/ASmall Molecule1 trial
+18 more programs
Active Trials
NCT02284074Completed15Est. Apr 2011
NCT00388765Completed10Est. Nov 2006
NCT00921466Unknown20Est. Aug 2009
+20 more trials
Novartis
21 programs
1
AEB071PHASE_1
AEB071PHASE_1
AHT956PHASE_1
AQW051PHASE_1
AQW051PHASE_1
+16 more programs
Abbott
AbbottABBOTT PARK, IL
20 programs
7
1
1
4
cefdinirPhase 41 trial
cefdinirPhase 41 trial
cefdinirPhase 41 trial
divalproex sodiumPhase 41 trial
Milk based formula APhase 2/31 trial
+15 more programs
Active Trials
NCT00718042Completed41,862Est. Sep 2009
NCT04862065Completed16,388Est. Aug 2021
NCT03285295Completed106,881Est. Jun 2018
+17 more trials
Colorado Therapeutics
1
1
SitagliptinPhase 4Small Molecule1 trial
LowTPhase 21 trial
Adenine 5+N/A
CannabidiolN/A1 trial
Cannabidiol CapsulesN/A1 trial
+13 more programs
Active Trials
NCT04881539Completed50Est. Mar 2022
NCT06364254Active Not Recruiting30Est. May 2024
NCT06254898Recruiting187Est. Aug 2026
+14 more trials
JW Pharmaceutical
17
1
Combiflex® lipid periPhase 41 trial
Epaminurad 9 mgPhase 11 trial
Epaminurad, NaproxenPhase 11 trial
Group 1: JW0104Phase 11 trial
JW2286Phase 11 trial
+13 more programs
Active Trials
NCT07374406Completed34Est. Feb 2026
NCT06435442Completed57Est. Dec 2025
NCT06378684Completed48Est. Jan 2024
+15 more trials
Medica Corp
16 programs
3
1
4
PentoxifyllinePhase 41 trial
Revolade®Phase 41 trial
Rivotril®Phase 41 trial
Theralite®Phase 41 trial
DLBS1033Phase 21 trial
+11 more programs
Active Trials
NCT01378585Completed20Est. Jul 2011
NCT06127212Completed24Est. May 2023
NCT03422575Completed26Est. Mar 2016
+13 more trials
AbbVie
AbbVieNORTH CHICAGO, IL
13 programs
12
1
onabotulinumtoxinAPhase 41 trial
ABBV-CLS-7262Phase 1
ABBV-CLS-7262Phase 1
ABBV-CLS-7262Phase 1
BIIB019 subcutaneous injectionPhase 1
+8 more programs
Active Trials
NCT01014650Completed53Est. Oct 2015
NCT03244228Completed120Est. Sep 2019
NCT01191723Completed54Est. Sep 2010
+5 more trials
Otsuka
13 programs
10
3
CilostazolPhase 41 trial
TolvaptanPhase 41 trial
probucolPhase 41 trial
ACU-4429Phase 11 trial
BrexpiprazolePhase 1Small Molecule1 trial
+8 more programs
Active Trials
NCT00942240Completed40Est. Apr 2010
NCT03734302Completed10Est. Jun 2020
NCT06143371Completed80Est. Nov 2025
+10 more trials
Bayer
12 programs
7
1
2
Climodien / LafammePhase 41 trial
YasminPhase 41 trial
YasminPhase 31 trial
DexpanthenolPhase 11 trial
MoxifloxacinPhase 1Small Molecule1 trial
+7 more programs
Active Trials
NCT00313118Withdrawn0Est. Dec 2016
NCT03003442Completed91Est. Oct 2017
NCT00885937Completed33Est. May 2009
+4 more trials
Medtronic
10 programs
1
1
3
Evaluation of propofol effectPhase 41 trial
Radical 7Phase 41 trial
Radical-7Phase 41 trial
Arterial linePhase 31 trial
Cleaning capsulePhase 11 trial
+5 more programs
Active Trials
NCT02506010Withdrawn0Est. Jan 2017
NCT02216344Completed13Est. Sep 2014
NCT00949208Completed1,225Est. Aug 2016
+7 more trials
Baxter
10 programs
5
1
recombinant human hyaluronidasePhase 4
ANCEF IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER(Cefazolin)Phase 1
CordaronePhase 1
MYXREDLIN(Insulin)Phase 1
PM10Phase 1
+5 more programs
Solventum
7 programs
4
2
AvagardPhase 41 trial
ChloraPrepPhase 41 trial
TiotropiumPhase 11 trial
TiotropiumPhase 11 trial
tiotropiumPhase 11 trial
+2 more programs
Active Trials
NCT04869696Completed56Est. May 2021
NCT03302065Completed38Est. Jan 2017
NCT02627625Completed31Est. Jun 2016
+4 more trials
Halozyme Therapeutics
5
2
HylenexPhase 41 trial
recombinant human hyaluronidasePhase 41 trial
Cohort 1: bococizumab 150 mg + rHuPH20Phase 11 trial
HylenexPhase 11 trial
OndansetronPhase 11 trial
+2 more programs
Active Trials
NCT02667223Terminated60Est. Jul 2016
NCT00435604Completed15Est. May 2007
NCT01572012Completed12Est. Nov 2013
+4 more trials
Enterprise Therapeutics
1
1
SertralinePhase 41 trial
ETD002 - single dosePhase 11 trial
rice protein RP-80NN/A1 trial
Active Trials
NCT05560048Unknown18Est. Jan 2023
NCT04488705Completed80Est. May 2021
NCT00969852Completed10Est. Mar 2010
Sound Pharmaceuticals
1
Suction-assisted LipoplastyPhase 41 trial
weighted waist-hoopingN/A1 trial
Active Trials
NCT04213560Completed27Est. Dec 2018
NCT00731354Completed21Est. Apr 2009
Amgen
AmgenTHOUSAND OAKS, CA
2 programs
1
1
leptinPhase 42 trials
HPN-100Phase 11 trial
Active Trials
NCT00977600Completed24Est. Jul 2005
NCT00121433Completed15Est. Dec 2004
NCT01207934Completed18Est. Jul 2000
Dr. Falk Pharma
2 programs
1
1
Budesonide 2 single doses, Metronidazole multiple-dosePhase 41 trial
UDCAPhase 11 trial
Active Trials
NCT00529009Completed
NCT00338910Completed12Est. Jun 2006
MCM Vaccines
1 program
1
Meningococcal BPhase 4
Currax Pharmaceuticals
1
Silenor 6 mgPhase 41 trial
Active Trials
NCT02353299Completed52Est. Mar 2016

+397 more companies

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
Johnson & JohnsonA
Johnson & JohnsonA
Johnson & JohnsonA
Merck & Co.Sotatercept
Johnson & JohnsonA
Medica CorpRivotril®
Johnson & JohnsonA
Medica CorpRevolade®
Johnson & JohnsonA
Medica CorpPentoxifylline
Johnson & JohnsonA
Johnson & JohnsonA
Medica CorpTheralite®
Johnson & JohnsonListerine Clinical Solutions Teeth Strength
Johnson & JohnsonA

Showing 15 of 49 trials with date data

Clinical Trials (50)

Total enrollment: 5,514 patients across 50 trials

The Relationship Between Risperdal Treatment and Quality of Life in Patients With Alzheimer's Disease and Behavioural and Psychological Symptoms of Dementia (BPSD)

Phase 4Unknown

Innovative Sternal Closure Techniques: Evaluating STRATAFIX™ and DERMABOND™ for Reduced Complications in CABG Patients

Start: May 2026Est. completion: May 2028401 patients
Phase 4Not Yet Recruiting

A Study to Evaluate the Efficacy of Guselkumab in Chinese Participants With Crohn's Disease (CD)

Start: Dec 2025Est. completion: Nov 202778 patients
Phase 4Recruiting

De-escalation of Ustekinumab Therapy in Patients With Crohn's Disease and Ulcerative Colitis

Start: Oct 2025Est. completion: Oct 2027115 patients
Phase 4Recruiting

Sotatercept in Pulmonary Arterial Hypertension

Start: Oct 2025Est. completion: Jan 203027 patients
Phase 4Recruiting

A Study of Guselkumab Administered Subcutaneously in Treatment of Indian Participants With Psoriatic Arthritis (PsA)

Start: Aug 2025Est. completion: Sep 2027100 patients
Phase 4Recruiting

Bioequivalence Study of Clonazepam 2 Mg Tablets

Start: Jun 2025Est. completion: Nov 202524 patients
Phase 4Not Yet Recruiting

A Study of Esketamine Nasal Spray in Korean Participants With Treatment-resistant Depression

Start: Jun 2025Est. completion: Jun 202747 patients
Phase 4Recruiting

Bioequivalence Study of Revolade® Eltrombopag 50 mg

Start: Jun 2025Est. completion: Oct 202530 patients
Phase 4Active Not Recruiting

A Study to Assess Safety of Teclistamab in Indian Participants With Relapsed and Refractory Multiple Myeloma

Start: May 2025Est. completion: Jun 202775 patients
Phase 4Recruiting

Bioequivalence Study of Pentoxifylline 400 Mg in Healthy Subjects Under Fasting and Fed Conditions

Start: Apr 2025Est. completion: Sep 202540 patients
Phase 4Not Yet Recruiting

Plan Development for Giving Teclistamab in the Outpatient Setting

Start: Nov 2024Est. completion: Oct 202615 patients
Phase 4Recruiting

Cefiderocol and Ampicillin-sulbactam vs. Colistin +/- Meropenem for Carbapenem Resistant A. Baumannii

Start: Sep 2024Est. completion: Sep 2026734 patients
Phase 4Recruiting

Bioequivalence Study of Lithium Carbonate 300 mg Tablets. Actilitio® in Healthy Subjects

Start: Jun 2024Est. completion: Apr 202524 patients
Phase 4Active Not Recruiting
NCT06136455Johnson & JohnsonListerine Clinical Solutions Teeth Strength

A Study to Investigate Salivary Flow and Potential of Hydrogen (pH) Following Use of Essential-Oil Containing Mouthwashes

Start: Nov 2023Est. completion: Nov 2023164 patients
Phase 4Completed

Positioning of Esketamine Treatment in the Real-world Management of Depression

Start: Oct 2023Est. completion: Jan 2026162 patients
Phase 4Recruiting
NCT06010758Johnson & JohnsonListerine Experimental Mouthwash

A Two-Week Study of an Anticavity Low pH Mouthwash

Start: Jul 2023Est. completion: Aug 2023163 patients
Phase 4Completed

Immune Spatial Features of Guselkumab Cutaneous Response

Start: Jul 2023Est. completion: Jun 202610 patients
Phase 4Recruiting

Effect of Biktarvy & Symtuza on microRNAs in HIV and Correlation With Weight Gain

Start: Mar 2023Est. completion: Mar 202530 patients
Phase 4Unknown
NCT05756673Johnson & JohnsonColgate Cavity Protection Toothpaste

A Study of Virtually Supervised Mouthwash and Interdental Brushes

Start: Feb 2023Est. completion: Oct 2023292 patients
Phase 4Completed

Home Based Daratumumab Administration for Patients With Multiple Myeloma

Start: Nov 2022Est. completion: May 202420 patients
Phase 4Completed
NCT05526586Johnson & JohnsonColgate Cavity Protection Toothpaste

A Twelve Week Study of Prototypes Mouth Rinses

Start: Aug 2022Est. completion: Dec 2022192 patients
Phase 4Completed
NCT05600231Johnson & JohnsonLISTERINE COOL MINT Antiseptic Mouthwash

A Study of Virtually Supervised Mouth Rinses and Flossing

Start: Apr 2022Est. completion: Jul 2022284 patients
Phase 4Completed

A Long-term Study for Participants Previously Treated With Ciltacabtagene Autoleucel

Start: Mar 2022Est. completion: Jan 2038295 patients
Phase 4Recruiting

A Study of Ustekinumab (STELARA) in Chinese Participants With Moderately to Severely Active Crohn's Disease

Start: Dec 2021Est. completion: May 2025182 patients
Phase 4Completed

Effect of Guselkumab on Cardiovascular Risk Surrogate Markers in Participants With Moderate to Severe Plaque Psoriasis

Start: Nov 2021Est. completion: Jul 202315 patients
Phase 4Terminated

A Study of Experimental Mouthwashes

Start: Nov 2021Est. completion: Apr 2022274 patients
Phase 4Completed

Rapid Reinitiation of a Single Tablet Antiretroviral Therapy Using Symtuza® in HIV-1 Infected Treatment-Experienced Patients Off Therapy. (ReSTART)

Start: Sep 2021Est. completion: Apr 202475 patients
Phase 4Completed

Study of Setmelanotide Effects on QTc (Corrected QT) Interval in Healthy Participants

Start: Aug 2021Est. completion: Apr 202277 patients
Phase 4Completed

A Study to Assess the Safety and Efficacy Of Tafamidis In Chinese Participants With Transthyretin Amyloid Cardiomyopathy (ATTR-CM)

Start: Jul 2021Est. completion: Oct 202353 patients
Phase 4Completed

A Long-Term Extension Study for Participants With Treatment-resistant Major Depressive Disorder Who Are Continuing Esketamine Nasal Spray Treatment

Start: Apr 2021Est. completion: Jul 2024183 patients
Phase 4Completed

Guselkumab Immunogenetics

Start: Mar 2021Est. completion: Apr 202625 patients
Phase 4Active Not Recruiting

A Study to Assess Safety of Canagliflozin and Metformin Hydrochloride Combination Given as a Supplement to Diet and Exercise to Improve Blood Sugar Level in Indian Adult Participants With Diabetes

Start: Nov 2020Est. completion: Jul 2022276 patients
Phase 4Completed

Study to Evaluate ctDNA of mCSPC Patients Receiving Apalutamide in Japan

Start: Nov 2020Est. completion: Mar 2025100 patients
Phase 4Unknown

A Study of Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (D/C/F/TAF) Evaluated as a Fixed Dose Combination Regimen in Participants Switching From an Integrase Inhibitor Who Have Experienced Rapid Weight Gain

Start: Jul 2020Est. completion: Aug 2023103 patients
Phase 4Completed
NCT04239339LundbeckEscitalopram 20 mg

Serotonergic Modulation of Cognition, Emotion and Brain Activation in Healthy Volunteers

Start: Apr 2020Est. completion: Oct 202266 patients
Phase 4Completed
NCT03794154PfizerCymbalta capsule

A Study Of Duloxetine Hydrochloride Hard Gelatinous Capsule Compared To Cymbalta Under Fed Conditions

Start: Mar 2020Est. completion: Jun 20200
Phase 4Withdrawn
NCT03729284PfizerCymbalta Capsules

A Study of Duloxetine Hydrochloride Hard Gelatinous Capsule Compared To Cymbalta

Start: Mar 2020Est. completion: Jun 20200
Phase 4Withdrawn

Synergistic Influence of Rivaroxaban on Inflammation and Coagulation Biomarkers in Patients With CAD and PAD on Aspirin Therapy

Start: Jan 2020Est. completion: Aug 202130 patients
Phase 4Unknown

A Study of Ibrutinib (PCI-32765) in Chinese Participants With Relapse or Refractory Waldenstrom's Macroglobulinemia (WM)

Start: Dec 2019Est. completion: Mar 202417 patients
Phase 4Completed

Integrase Regimen Switch to Symtuza to Increase Tolerability/Adherence (SYMita)

Start: Sep 2019Est. completion: Dec 20211 patients
Phase 4Terminated

Switching From DAPT to Dual Pathway Inhibition With Low-dose Rivaroxaban in Adjunct to Aspirin in Patients With Coronary Artery Disease

Start: Sep 2019Est. completion: May 202290 patients
Phase 4Completed

A Study of Itraconazole in the Management of Superficial Fungal Infections in India

Start: Aug 2019Est. completion: Mar 202040 patients
Phase 4Terminated

A Study to Assess Safety of ImbruvicaTM in Indian Participants With Chronic Lymphocytic Leukemia or Mantle Cell Lymphoma Who Have Received at Least One Prior Therapy or Chronic Lymphocytic Leukemia With 17p Deletion

Start: Jun 2019Est. completion: May 202375 patients
Phase 4Completed

A Study of DARZALEX (Daratumumab) In Indian Participants With Relapsed and Refractory Multiple Myeloma, Whose Prior Therapy Included a Proteasome Inhibitor and an Immunomodulatory Agent

Start: Jun 2019Est. completion: Jul 2022150 patients
Phase 4Completed
NCT03803371PfizerUltracet Tablets

Bioequivalence Study of Tramadol Hydrochloride /Paracetamol Tablets Versus Ultracet Tablets

Start: Mar 2019Est. completion: Jun 201960 patients
Phase 4Completed

Pharmacodynamic Effects of Low-dose Rivaroxaban With Antiplatelet Therapies

Start: Jan 2019Est. completion: Aug 202086 patients
Phase 4Completed

A Study of Golimumab in the Treatment of Indian Participants With Active Spondyloarthropathy of Ankylosing Spondylitis or Psoriatic Arthritis

Start: Jan 2019Est. completion: Nov 2021100 patients
Phase 4Completed

A Clinical Trial to Evaluate the Reversibility of Abacavir/Lamivudine/Dolutegravir CNS-Related Neurotoxicity After Switching to Tenofovir/Alafenamide/Emtricitabine/Darunavir/Cobicistat (TAF/FTC/DRV/c)

Start: Dec 2018Est. completion: Jun 202078 patients
Phase 4Completed
NCT03711708PfizerZoloft Oral Solution

Relative Bioavailability Study of Zoloft Oral Solution to Zoloft Tablets

Start: Nov 2018Est. completion: Feb 201936 patients
Phase 4Completed

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

20 late-stage (Phase 3) programs, potential near-term approvals
11 actively recruiting trials targeting 5,514 patients
30 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.